Xeris Biopharma Holdings Investor Relations Material
Latest events
Q3 2024
Xeris Biopharma Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Xeris Biopharma Holdings Inc
Access all reports
Xeris Biopharma Holdings Inc. is a pharmaceutical company focused on developing and commercializing innovative therapies for patients with endocrine and metabolic disorders, as well as other conditions requiring injectable treatments. The company's technology platform enables the formulation of ready-to-use injectable medications that do not require reconstitution, refrigeration, or complex preparation. The company is headquartered in Chicago, Illinois, and its shares are listed on the NASDAQ.
Key slides for Xeris Biopharma Holdings Inc
Corporate Presentation
Xeris Biopharma Holdings Inc
Corporate Presentation
Xeris Biopharma Holdings Inc
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
XERS
Country
🇺🇸 United States